Autopsy report · NCT02139761
L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder
Cause of deathFunding or business
“Study funding has not been established”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University, hospital or other
- Conditions
- Cocaine Use
- Interventions
- l-tetrahydropalmatine (l-THP); Placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Augmented Reality-based Telerehabilitation Platform for Patients With Stroke
“Study did not receive funding” - Vasomotor Symptoms and Cardiovascular Control
“No funding obtained to conduct study” - Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
“No funding for the study” - Xanthine Oxidase Inhibition in Renal Transplant Recipients
“Study was not funded” - Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
“Unable to obtain funding to initiate/complete study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.